Clinical Trial Update: Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating eltrombopag in combination with immunosuppressive therapy for East-Asian patients with severe aplastic anemia has completed and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Severe Aplastic Anemia (SAA) | Phase 2 | Status: COMPLETED | Results posted: 2025-07-17